One in seven Americans has diabetes, and many do not even know they have the blood sugar disease, a new report shows.
According to the US Centres for Disease Control and Prevention, 14% of US adults have diabetes , 10% know it and more than 4% are diagnosed.
ImmuPharma PLC (LON:IMM) is headquartered in London and has its research operations in France (ImmuPharma (France) SA) and Switzerland (ImmuPharma AG). ImmuPharma is dedicated to the development of innovative drugs to treat serious medical conditions, characterised by High unmet medical need, Low marketing costs and Relatively low development costs.